Interpreting Benign Pathology Intraductal Microcalcifications
Hello all first time poster. I am a 39F classified as high risk with a 40% lifetime risk of developing breast cancer due to family history (no gene mutations) and previous biopsy result of Usual Ductal Hyperplasia (my understanding slightly increases risk). I go in for 6 month screenings for the last 4 years; rotating MRI and mammogram.
I had a biopsy in 2018 for microcalcifications that resulted in in Proliferative fibrocystic changes with central area of dense fibrosis, duct ectasia, usual ductal hyperplasia and multifocal associated calcifications, NO In Situ or invasive malignancy.
Most recent MRI resulted in Bi-rads 4 and MRI guided biopsy. I received quite vague results on path report today (my recent one was far more descriptive). I asked the nurse what it meant and all she said was that the Microcalcifications is what was making the MRI light up... I asked her if it mentioned hyperplasia and she said no mention of it and shared the report with. I have inquired if there is a more in-depth report as I like to keep informed. I'd like to have a better understanding of this to weigh my options proceeding into the future as the 40% risk already gives me anxiety and now add multiple biopsies on the same breast. I suffer from anxiety so this doesn't help me. Can someone provide a little insight on what "rare focus of intraductal microcalcifications" means?
Most recent report has final diagnosis as:
Right breast, 16 mm area of nonmass-like enhancement, MRI-guided Suros 9 gauge vacuum assisted needle core biopsies:
- Fibrofatty breast tissue with rare focus of intraductal microcalcification.,
- Negative for atypia and malignancy.